Bisphosphonates in the treatment of metabolic bone diseases (Q40769942)

23 September 2017

1 reference

title

Bisphosphonates in the treatment of metabolic bone diseases (English)

1 reference

23 September 2017

Rodan GA

1

1 reference

PubMed ID

8217103

23 September 2017

Balena R

series ordinal

2

1 reference

PubMed ID

8217103

23 September 2017

language of work or name

English

0 references

publication date

1 August 1993

1 reference

23 September 2017

1 reference

23 September 2017

25

1 reference

23 September 2017

4

1 reference

23 September 2017

373-378

1 reference

Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease

23 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

The inhibition of calcium hydroxypatite crystal growth by polyphosphonates and polyphosphates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Hypercalcemia of malignancy revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Parathyroid hormone-related protein of malignancy: immunohistochemical and biochemical studies in normocalcaemic and hypercalcaemic patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effects of amino-butylidene diphosphonate in hypercalcemia due to malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Diet and gastric cancer. A case-control study in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Efficacy and safety of the bisphosphonate tiludronate for the treatment of tumor-associated hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effects of a new aminodiphosphonate (aminohydroxybutylidene diphosphonate) in patients with osteolytic lesions from metastases and myelomatosis. Comparison with dichloromethylene diphosphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Diphosphonate Therapy of Paget's Disease of Bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Short-term effects on bone and mineral metabolism of 4-amino-1-hydroxybutylidene-1,1-diphosphonate (ABDP) in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effects of five daily 1 h infusions of alendronate in Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Long-term effects of ovariectomy and aging on the rat skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Prevention of postmenopausal bone loss by tiludronate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

A new direction for osteoporosis research: A review and proposal

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Mechanical loading, estrogen deficiency, and the coupling of bone formation to bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Axial and appendicular bone density predict fractures in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Prediction of postmenopausal fracture risk with use of bone mineral measurements.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

Controlled Clinical Study on the Use of Dichloromethylene Diphosphonate in Patients with Breast Carcinoma Metastasizing to the Skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07853899309147299

10.3109/07853899309147299

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference

PubMed ID

8217103